(Q43670866)
Statements
Phase I and pharmacological study of the oral matrix metalloproteinase inhibitor, MMI270 (CGS27023A), in patients with advanced solid cancer (English)
Levitt NC
Eskens FA
O'Byrne KJ
Propper DJ
Denis LJ
Owen SJ
Choi L
Foekens JA
Wilner S
Wood JM
Nakajima M
Talbot DC
Steward WP
Harris AL